252 related articles for article (PubMed ID: 29876274)
1.
Townley RA; Botha H; Graff-Radford J; Boeve BF; Petersen RC; Senjem ML; Knopman DS; Lowe V; Jack CR; Jones DT
Neuroimage Clin; 2018; 18():897-902. PubMed ID: 29876274
[TBL] [Abstract][Full Text] [Related]
2. The metabolic spatial covariance pattern of definite idiopathic normal pressure hydrocephalus: an FDG PET study with principal components analysis.
Rau A; Schröter N; Blazhenets G; Maurer C; Urbach H; Meyer PT; Frings L
Alzheimers Res Ther; 2023 Nov; 15(1):202. PubMed ID: 37980531
[TBL] [Abstract][Full Text] [Related]
3. Amygdala sign, a FDG-PET signature of dementia with Lewy Bodies.
Pillai JA; Wu G; Tousi B; Larvie M; Léger GC; Leverenz JB
Parkinsonism Relat Disord; 2019 Jul; 64():300-303. PubMed ID: 30905401
[TBL] [Abstract][Full Text] [Related]
4. Brain positron emission tomography in idiopathic normal-pressure hydrocephalus: new 18 F-fluorodeoxyglucose pattern in a long-known syndrome.
Cistaro A; Quartuccio N; Piccardo A; Meo G; Gandoglia I; Schiera IG; Fania P; Lupidi F; Bottoni G; Massollo M; Altrinetti V; Pestarino E; Iacozzi M; Iantorno M; Del Sette M
Nucl Med Commun; 2023 Dec; 44(12):1163-1167. PubMed ID: 37779439
[TBL] [Abstract][Full Text] [Related]
5. Syndrome-specific patterns of regional cerebral glucose metabolism in posterior cortical atrophy in comparison to dementia with Lewy bodies and Alzheimer's disease--a [F-18]-FDG pet study.
Spehl TS; Hellwig S; Amtage F; Weiller C; Bormann T; Weber WA; Hüll M; Meyer PT; Frings L
J Neuroimaging; 2015; 25(2):281-288. PubMed ID: 24593796
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of Brain Positron Emission Tomography with Different Tracers in the Evaluation of Patients with Idiopathic Normal Pressure Hydrocephalous.
Mattoli MV; Treglia G; Calcagni ML; Mangiola A; Anile C; Trevisi G
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32906629
[TBL] [Abstract][Full Text] [Related]
7. Differential diagnosis of neurodegenerative dementias using metabolic phenotypes on F-18 FDG PET/CT.
Tripathi M; Tripathi M; Damle N; Kushwaha S; Jaimini A; D'Souza MM; Sharma R; Saw S; Mondal A
Neuroradiol J; 2014 Feb; 27(1):13-21. PubMed ID: 24571830
[TBL] [Abstract][Full Text] [Related]
8. Clinical profiles of dementia with Lewy bodies with and without Alzheimer's disease-like hypometabolism.
Chiba Y; Fujishiro H; Ota K; Kasanuki K; Arai H; Hirayasu Y; Sato K; Iseki E
Int J Geriatr Psychiatry; 2015 Mar; 30(3):316-23. PubMed ID: 24839913
[TBL] [Abstract][Full Text] [Related]
9. Evaluating 2-[
Gjerum L; Frederiksen KS; Henriksen OM; Law I; Bruun M; Simonsen AH; Mecocci P; Baroni M; Dottorini ME; Koikkalainen J; Lötjönen J; Hasselbalch SG
Neuroimage Clin; 2020; 27():102267. PubMed ID: 32417727
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Value of Diffusion Tensor Imaging and Positron Emission Tomography in Early Stages of Frontotemporal Dementia.
Krämer J; Lueg G; Schiffler P; Vrachimis A; Weckesser M; Wenning C; Pawlowski M; Johnen A; Teuber A; Wersching H; Meuth SG; Duning T
J Alzheimers Dis; 2018; 63(1):239-253. PubMed ID: 29614640
[TBL] [Abstract][Full Text] [Related]
11. Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria.
Caminiti SP; Sala A; Iaccarino L; Beretta L; Pilotto A; Gianolli L; Iannaccone S; Magnani G; Padovani A; Ferini-Strambi L; Perani D
Alzheimers Res Ther; 2019 Feb; 11(1):20. PubMed ID: 30797240
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Network Topology of Alzheimer's Disease and Dementia with Lewy Bodies Generated Using Fluorodeoxyglucose Positron Emission Tomography.
Imai M; Tanaka M; Sakata M; Wagatsuma K; Tago T; Toyohara J; Sengoku R; Nishina Y; Kanemaru K; Ishibashi K; Murayama S; Ishii K
J Alzheimers Dis; 2020; 73(1):197-207. PubMed ID: 31771066
[TBL] [Abstract][Full Text] [Related]
13. The Cingulate Island Sign on FDG-PET vs. IMP-SPECT to Assess Mild Cognitive Impairment in Alzheimer's Disease vs. Dementia with Lewy Bodies.
Chiba Y; Fujishiro H; Iseki E; Kasanuki K; Sato K
J Neuroimaging; 2019 Nov; 29(6):712-720. PubMed ID: 31199036
[TBL] [Abstract][Full Text] [Related]
14. Brain
Woyk K; Sahlmann CO; Hansen N; Timäus C; Müller SJ; Khadhraoui E; Wiltfang J; Lange C; Bouter C
J Neuroimaging; 2023 Mar; 33(2):256-268. PubMed ID: 36465027
[TBL] [Abstract][Full Text] [Related]
15. Early differential diagnosis between Alzheimer's disease and dementia with Lewy bodies: Comparison between (18)F-FDG PET and (123)I-IMP SPECT.
Chiba Y; Iseki E; Fujishiro H; Ota K; Kasanuki K; Suzuki M; Hirayasu Y; Arai H; Sato K
Psychiatry Res Neuroimaging; 2016 Mar; 249():105-12. PubMed ID: 26857415
[TBL] [Abstract][Full Text] [Related]
16. The Use of
Ortner MM
Methods Mol Biol; 2018; 1750():213-219. PubMed ID: 29512075
[TBL] [Abstract][Full Text] [Related]
17. The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies.
Lim SM; Katsifis A; Villemagne VL; Best R; Jones G; Saling M; Bradshaw J; Merory J; Woodward M; Hopwood M; Rowe CC
J Nucl Med; 2009 Oct; 50(10):1638-45. PubMed ID: 19759102
[TBL] [Abstract][Full Text] [Related]
18. Association between the Onset of Idiopathic Normal Pressure Hydrocephalus Symptoms and Reduced Default Mode Network Connectivity.
Miyazaki K; Hanaoka K; Kaida H; Chiba Y; Ishii K
Dement Geriatr Cogn Disord; 2020; 49(3):255-263. PubMed ID: 32814322
[TBL] [Abstract][Full Text] [Related]
19. Distinguishing between dementia with Lewy bodies and Alzheimer's disease using metabolic patterns.
Ye BS; Lee S; Yoo H; Chung SJ; Lee YH; Choi Y; Lee PH; Sohn YH; Yun M
Neurobiol Aging; 2020 Mar; 87():11-17. PubMed ID: 31791660
[TBL] [Abstract][Full Text] [Related]
20. Two distinct pathological substrates associated with MMSE-pentagons item deficit in DLB and AD.
Beretta L; Caminiti SP; Santangelo R; Magnani G; Ferrari-Pellegrini F; Caffarra P; Perani D
Neuropsychologia; 2019 Oct; 133():107174. PubMed ID: 31446008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
